99 related articles for article (PubMed ID: 23102678)
21. Elevated plasma big ET-1 is associated with distant failure in patients with advanced-stage nasopharyngeal carcinoma.
Mai HQ; Zeng ZY; Zhang CQ; Feng KT; Guo X; Mo HY; Deng MQ; Min HQ; Hong MH
Cancer; 2006 Apr; 106(7):1548-53. PubMed ID: 16518816
[TBL] [Abstract][Full Text] [Related]
22. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
[TBL] [Abstract][Full Text] [Related]
23. Elevated Serum Pancreastatin Is an Indicator of Hepatic Metastasis in Patients With Small Bowel Neuroendocrine Tumors.
Khan TM; Garg M; Warner RR; Uhr JH; Divino CM
Pancreas; 2016 Aug; 45(7):1032-5. PubMed ID: 26684860
[TBL] [Abstract][Full Text] [Related]
24. Elevated plasma TGF-beta1 levels correlate with decreased survival of metastatic breast cancer patients.
Ivanović V; Demajo M; Krtolica K; Krajnović M; Konstantinović M; Baltić V; Prtenjak G; Stojiljković B; Breberina M; Nesković-Konstantinović Z; Nikolić-Vukosavljević D; Dimitrijević B
Clin Chim Acta; 2006 Sep; 371(1-2):191-3. PubMed ID: 16650397
[TBL] [Abstract][Full Text] [Related]
25. Plasma neuroendocrine markers in patients with benign prostatic hyperplasia and prostatic carcinoma.
Cussenot O; Villette JM; Valeri A; Cariou G; Desgrandchamps F; Cortesse A; Meria P; Teillac P; Fiet J; Le Duc A
J Urol; 1996 Apr; 155(4):1340-3. PubMed ID: 8632569
[TBL] [Abstract][Full Text] [Related]
26. Nuclear survivin is a powerful novel prognostic marker in gastroenteropancreatic neuroendocrine tumor disease.
Grabowski P; Griss S; Arnold CN; Hörsch D; Göke R; Arnold R; Heine B; Stein H; Zeitz M; Scherübl H
Neuroendocrinology; 2005; 81(1):1-9. PubMed ID: 15809513
[TBL] [Abstract][Full Text] [Related]
27. Endocrine tumors of the small and large intestine.
Solcia E; Fiocca R; Rindi G; Villani L; Luinetti O; Burrell M; Bosi F; Silini E
Pathol Res Pract; 1995 May; 191(4):366-72. PubMed ID: 7479353
[TBL] [Abstract][Full Text] [Related]
28. Number, not size, of mesenteric tumor deposits affects prognosis of small intestinal well-differentiated neuroendocrine tumors.
Gonzalez RS; Cates JMM; Shi C
Mod Pathol; 2018 Oct; 31(10):1560-1566. PubMed ID: 29795438
[TBL] [Abstract][Full Text] [Related]
29. Small bowel malignancies: a review of 29 patients at a single centre.
Kam MH; Barben CP; Eu KW; Seow-Choen F
Colorectal Dis; 2004 May; 6(3):195-7. PubMed ID: 15109386
[TBL] [Abstract][Full Text] [Related]
30. The importance of the measurement of circulating markers in patients with neuroendocrine tumours of the pancreas and gut.
Ardill JE; Erikkson B
Endocr Relat Cancer; 2003 Dec; 10(4):459-62. PubMed ID: 14713258
[TBL] [Abstract][Full Text] [Related]
31. Small intestinal neuroendocrine cell pathobiology: 'carcinoid' tumors.
Kidd M; Modlin IM
Curr Opin Oncol; 2011 Jan; 23(1):45-52. PubMed ID: 21045686
[TBL] [Abstract][Full Text] [Related]
32. Surgical management and outcome in primary adenocarcinoma of the small bowel.
Agrawal S; McCarron EC; Gibbs JF; Nava HR; Wilding GE; Rajput A
Ann Surg Oncol; 2007 Aug; 14(8):2263-9. PubMed ID: 17549572
[TBL] [Abstract][Full Text] [Related]
33. Histologic characterization and improved prognostic evaluation of 209 gastric neuroendocrine neoplasms.
La Rosa S; Inzani F; Vanoli A; Klersy C; Dainese L; Rindi G; Capella C; Bordi C; Solcia E
Hum Pathol; 2011 Oct; 42(10):1373-84. PubMed ID: 21531442
[TBL] [Abstract][Full Text] [Related]
34. Neuroendocrine differentiation in colorectal carcinomas.
Syversen U; Halvorsen T; Mårvik R; Waldum HL
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):667-74. PubMed ID: 8590163
[TBL] [Abstract][Full Text] [Related]
35. Principal component analysis, hierarchical clustering, and decision tree assessment of plasma mRNA and hormone levels as an early detection strategy for small intestinal neuroendocrine (carcinoid) tumors.
Modlin IM; Gustafsson BI; Drozdov I; Nadler B; Pfragner R; Kidd M
Ann Surg Oncol; 2009 Feb; 16(2):487-98. PubMed ID: 19050963
[TBL] [Abstract][Full Text] [Related]
36. Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes.
Aguayo A; Kantarjian HM; Estey EH; Giles FJ; Verstovsek S; Manshouri T; Gidel C; O'Brien S; Keating MJ; Albitar M
Cancer; 2002 Nov; 95(9):1923-30. PubMed ID: 12404286
[TBL] [Abstract][Full Text] [Related]
37. [Pulmonary neuroendocrine tumors. The spectrum of histologic subtypes and current concept on diagnosis and treatment].
Langfort R; Rudziński P; Burakowska B
Pneumonol Alergol Pol; 2010; 78(1):33-46. PubMed ID: 20162517
[TBL] [Abstract][Full Text] [Related]
38. Primary small intestinal malignant tumors: survival analysis of 48 postoperative patients.
Cao J; Zuo Y; Lv F; Chen Z; Li J
J Clin Gastroenterol; 2008 Feb; 42(2):167-73. PubMed ID: 18209587
[TBL] [Abstract][Full Text] [Related]
39. [Neuroendocrine tumors of the lung].
Oliaro A; Donati G; Filosso PL; Ruffini E
Minerva Chir; 2000; 55(1-2):7-16. PubMed ID: 10832278
[TBL] [Abstract][Full Text] [Related]
40. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients.
Dabaja BS; Suki D; Pro B; Bonnen M; Ajani J
Cancer; 2004 Aug; 101(3):518-26. PubMed ID: 15274064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
